Office Locations:

University of California, San Francisco
1700 4th Street, Byers Hall, Suite 214, QB3 MC: 2522
San Francisco, CA 94158-2330
Phone: 415-514-9790



  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    QB3 is a consortium of three University of California campuses-UC Berkeley, UC Santa Cruz, and UCSF-that serves both science and society. The group fosters collaborations among scientific faculty that enhance innovation and discovery. Initiatives include: the Innolab, which manages the consortium's industry partnerships with companies such as Pfizer, GE Healthcare Life Sciences, and Johnson & Johnson; and startup support, which guides researchers from the precommercial stage to efficient operational companies. Startup services include the QB3 Startup in a Box, the organization's standard package designed to take an entrepreneur from an idea to a successful SBIR application; the QB3 Garage/Innovation Network; and the organization's seed-stage venture capital fund, Mission Bay Capital. QB3 starts new companies by assembling management teams, providing research space and identifying potential funding sources. The group created the QB3 Garage, the first start-up incubator within the University of California system. Since its inception, three of its first six companies closed venture capital funding of more than $5 million, and one was acquired at an early stage for a reported $25 million.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Christine Winoto Assistant Director
    David Haussler Ph.D. Campus Director
    Douglas Crawford Ph.D. Associate Director
    Herminio Neto Program Coordinator
    Kaspar Mossman Ph.D. Director of Communications and Marketing


    Portfolio companies include:

        web link

        web link

      Aquinox Pharmaceuticals
        web link

      BioMark Technologies
        web link

      Caribou Biosciences
        web link

        web link

        web link

        web link

      Pivot Bio
        web link

      SeaChange Pharmaceuticals
        web link

      Silicon BioDevices
        web link

      Symic Biomedical
        web link

        web link

        web link

      ZoneOne Pharma
        web link


    Recent News: